Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect in a few days, on January 31, 2022?

This regulation mandates that layperson summaries of clinical trials be submitted within 1 year of trial completion.

Why are clinical trial summaries important, you ask?

Because they improve health literacy, which is crucial to increasing trust in pharma.

Watch our latest video to learn more about clinical trial summaries and how your medical affairs team can make them part of your strategy.

About the author

Cactus Life Sciences
+ posts

Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world ─ with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.